Soleno Therapeutics (SLNO) Assets: 2013-2018
Historic Assets for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $43.2 million.
- Soleno Therapeutics' Assets fell 6.84% to $28.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $28.7 million, marking a year-over-year decrease of 6.84%. This contributed to the annual value of $43.2 million for FY2018, which is 10.58% up from last year.
- According to the latest figures from FY2018, Soleno Therapeutics' Assets is $43.2 million, which was up 10.58% from $39.0 million recorded in FY2017.
- In the past 5 years, Soleno Therapeutics' Assets ranged from a high of $43.2 million in FY2018 and a low of $5.6 million during FY2016.
- Moreover, its 3-year median value for Assets was $39.0 million (2017), whereas its average is $29.2 million.
- In the last 5 years, Soleno Therapeutics' Assets slumped by 32.15% in 2016 and then soared by 601.22% in 2017.
- Soleno Therapeutics' Assets (Yearly) stood at $8.4 million in 2014, then decreased by 2.32% to $8.2 million in 2015, then slumped by 32.15% to $5.6 million in 2016, then soared by 601.22% to $39.0 million in 2017, then climbed by 10.58% to $43.2 million in 2018.